SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech News
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Doc Bones7/26/2009 11:09:51 AM
  Read Replies (1) of 7143
 
A Biochemical Way to Reduce Drug Side Effects?

An emerging class of medicines works its magic by targeting unusual sites on biological molecules

From the August 2009 Scientific American Magazine
By Melinda Wenner


Key Concepts

A new drug discovery approach focuses on a property known as allosterism.

Allosteric drugs attach to biological molecules at binding sites distinct from those usually targeted
by medications.

Instead of activating or inhibiting the bound molecules, as classic drugs do, allosteric types can act more like dimmer switches and might, at times, cause fewer side effects.

Such agents may be able to treat disorders that lack drug therapies today.

[continued at:]

scientificamerican.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News